세계 세포 증식 시장 : 제품 유형별, 세포 유형별, 용도별, 최종 사용자별 예측(-2029년)

Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029

US $ 4,950 ￦ 7,159,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,617,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,787,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,463,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세포 증식 시장 규모는 2024년 143억 달러에서 2029년 267억 달러에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR) 13.3%를 나타낼 것으로 보입니다.

이 시장의 성장은 만성 질환의 유병률 증가로 인한 것입니다. 암 등 만성질환 증가율은 세포 및 유전자 치료, 조직공학, 재생의료 등 세포 기반 치료의 필요성을 뒷받침하고 있습니다. 혁신적인 세포 기반 치료법과 신규 치료법에 대한 수요 증가가 세포 증식의 필요성을 뒷받침하고 있습니다. 이러한 추세는 향후 수년간 세포 증식 시장의 성장을 가속할 것으로 예상됩니다.

조사 범위
조사 대상년도	2022년-2029년
기준년	2023년
예측 기간	2024년-2029년
검토 단위	금액(10억 달러)
부문	제품 유형별, 셀 유형별, 용도별, 최종 사용자별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

2023년 세계 세포 증식 시장에서 바이오 의약품 생산 부문은 용도별 부문에서 가장 큰 점유율을 차지했습니다. 바이오 의약품 생산에는 단클론항체 생산, 백신 생산 및 기타 치료용 단백질 생산이 포함됩니다. 신약 개발을 위한 투자와 자금 조달 신흥국 시장 확대, 단클론항체, 백신, 치료용 단백질 등 생물학적 요법에 대한 수요 증가가 세포 증식 시장에서 바이오의약품 제조의 성장을 가속하고 있습니다.

2023년 북미의 세포 증식 시장은 미국이 독점하고 있습니다. 미국은 세계 최대의 바이오 의약품 시장이며 바이오 의약품 연구/투자 리더입니다. 또한 미국에는 하버드 대학, 스탠포드 대학, 매사추세츠 공과 대학(MIT) 등 세계 최고의 학술 연구 기관이 있습니다. 이러한 연구기관은 창약과 생명공학을 포함한 생명과학 분야에서 최첨단 연구를 하고 있으며, 세포증식기술의 도입을 수반하여 시장의 성장을 뒷받침하는 결과가 되고 있습니다. 게다가 조직공학 및 재생의료 분야에서의 자금 조달 증가도 세포 증식 시장의 성장을 뒷받침하고 있습니다.

본 보고서에서는 세계 세포 증식 시장에 대해 조사했으며, 제품 유형별, 세포 유형별, 용도별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 소개
• 시장 역학
• 기술 분석
• 무역 데이터
• 공급망 분석
• 밸류체인 분석
• 가격 분석
• 생태계 분석
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 특허 분석
• 주요 회의 및 이벤트
• 규제 상황
• Porter's Five Forces 분석
• 주요 이해관계자와 구매 기준
• 투자,자금 제공 활동

제6장 세포 증식 시장 : 제품 유형별

• 소개
• 소모품
• 장치

제7장 세포 증식 시장 : 세포 유형별

• 소개
• 인간 세포
• 동물 세포
• 기타

제8장 세포 증식 시장 : 용도별

• 소개
• 바이오의약품 생산
• 조직 공학 및 재생 의료
• 약제의 스크리닝과 개발
• 기타

제9장 세포 증식 시장 : 최종 사용자별

• 소개
• 제약회사 및 바이오테크놀러지 기업
• 연구 및 학술기관
• 병원 및 진단실험실
• 기타

제10장 세포 증식 시장 : 지역별

• 소개
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제11장 경쟁 구도

• 개요
• 주요 참가 기업이 채용한 전략/비책
• 수익 점유율 분석
• 시장 점유율 분석
• 브랜드/제품 비교 분석
• 기업 평가 매트릭스 : 주요 기업
• 기업의 발자취: 주요 진출기업
• 기업 평가 매트릭스 : 스타트업/중소기업
• 세포 증식 벤더의 평가와 재무 지표
• 경쟁 시나리오

제12장 기업 프로파일

• 소개
• 주요 진출기업
  • THERMO FISHER SCIENTIFIC INC.
  • DANAHER CORPORATION
  • MERCK KGAA
  • SARTORIUS AG
  • CORNING INCORPORATED
  • LONZA
  • TERUMO CORPORATION
  • EPPENDORF SE
  • FUJIFILM CORPORATION
  • BIO-TECHNE
  • REPLIGEN CORPORATION
  • GETINGE AB
  • BD
  • MILTENYI BIOTEC
  • PERKINELMER INC.
  • STEMCELL TECHNOLOGIES
  • PROMOCELL GMBH
  • HIMEDIA LABORATORIES
• 기타 기업
  • TAKARA BIO INC.
  • SHANGHAI DUONING BIOTECHNOLOGY CO., LTD.
  • REPROCELL INC.
  • ACROBIOSYSTEMS
  • SOLIDA BIOTECH GMBH
  • BEIJING CYTONICHE BIOTECHNOLOGY CO., LTD.
  • NEUROMICS
  • BIONET
  • CELLEXUS

제13장 부록

BJH

영문 목차

영문목차

The cell expansion market is projected to reach USD 26.7 billion by 2029 from an estimated USD 14.3 billion in 2024, at a CAGR of 13.3% during the forecast period of 2024 to 2029. The growth of this market can be attributed to increasing prevalence of chronic diseases. The rising rate of chronic diseases such as cancer is propelling the need of cell based therapies such as cell & gene therapy, tissue engineering, and regenerative medicine. The rising deamd for innovative cell based therapies and novel therapeutics is propelling the need of cell expansion. This trend is expected to drive the growth of the cell expansion market in the coming years.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD) Billion
Segments	Product, Cell Type, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

"The biopharmaceutical production segment accounted for the largest share of by application segment in 2023."

In 2023, the biopharmaceutical production segment accounted for the largest share of by application segment in the global cell expansion market. Biopharmaceutical production include monoclonal antibody production, vaccine production, and other therapeutic protein production. The growing investments and fundings for the development of novel drug products and rising demand for biological therapies such as monoclonal antibosies, vaccines, and therapeutic proteins are promoting the growth of biopharmaceutical production in cell expansion market.

"The US has continued to dominate the cell expansion market during the forecast period of 2024-2029."

The US dominated the cell expansion market in North America in 2023. The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Additionally, the US is home to some of the world's leading academic research institutes, including Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT). These institutes conduct cutting-edge research in life sciences, including drug discovery and biotechnology, which involve adoption of cell expansion techniques, resulting to propel the market growth. Additionally, increasing fundings in the field of tissue engineering and regenerative medicine are also driving the growth of cell expansion market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: Managers - 55%, CXO & Directors - 20%, and Executives - 25%
• By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Danaher Corporation (US)
• Merck KGaA (Germany)
• Sartorius AG (Germany)
• Corning Incorporated (US)
• Lonza (Switzerland)
• Terumo Corporation (Japan)
• Eppendorf SE (Germany)
• FUJIFILM Corporation (Japan)
• Bio-Techne (US)
• Repligen Corporation (US)
• Getinge AB (Sweden)
• Miltenyi Biotec (Germany)
• PerkinElmer Inc. (US)
• STEMCELL Technologies (Canada)
• PromoCell GmBHGmbH (Germany)
• HiMedia Laboratories (India)
• BD (US)
• Takara Bio Inc. (Japan)
• Shanghai Duoning Biotechnology Co., Ltd. (Japan)
• REPROCELL Inc. (Japan)
• PBS Biotech, Inc. (US)
• ACROBiosystems (US)
• Solida Biotech GmBH (Germany)
• Beijing CytoNiche Biotechnology Co., Ltd. (China)
• Neuromics (US)
• Bionet (Spain)
• Cellexus (UK)

Research Coverage:

This research report categorizes the cell expansion market by product (consumables and equipment), by cell type (human cells, animal cells, and other cell types), by application (biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, and other applications), by end user (pharmaceutical & biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell expansion market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. Also, it include new product launches, collaborations and acquisitions, and recent developments associated with the cell expansion market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell expansion market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (increasing prevalence of chronic diseases, rising investments and fundings in cell based research, and growing strategic alliances for the development of biotechnology industry), restraints (high cost of cell based therapies and ethical concern regarding cell biology), opportunities (growing opportunities in emerging economies, advances in 3D cell expansion technology), and Challenges (concern regarding supply chain and logistics) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the cell expansion market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell expansion market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany), Corning Incorporated (US), Lonza (Switzerland), Terumo Corporation (Japan), Eppendorf SE (Germany), FUJIFILM Corporation (Japan), Bio-Techne (US), Repligen Corporation (US), Getinge AB (Sweden), Miltenyi Biotec (Germany), PerkinElmer Inc. (US), STEMCELL Technologies (Canada), PromoCell GmBH (Germany), HiMedia Laboratories (India), BD (US), Takara Bio Inc. (Japan), Shanghai Duoning Biotechnology Co., Ltd. (Japan), REPROCELL Inc. (Japan), PBS Biotech, Inc. (US), ACROBiosystems (US), Solida Biotech GmBH (Germany), Beijing CytoNiche Biotechnology Co., Ltd. (China), Neuromics (US), Bionet (Spain), and Cellexus (UK), among others in the market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 REGIONS COVERED
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY
• 1.6 STAKEHOLDERS
• 1.7 LIMITATIONS
• 1.8 SUMMARY OF CHANGES
• 1.9 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 BREAKDOWN OF PRIMARIES: CELL EXPANSION MARKET
• 2.2 MARKET ESTIMATION METHODOLOGY
  • FIGURE 3 CELL EXPANSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
• 2.3 BOTTOM-UP APPROACH
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC. (2023)
• 2.4 INSIGHTS FROM PRIMARY EXPERTS
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
• 2.5 TOP-DOWN APPROACH
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• 2.6 GROWTH FORECAST
  • FIGURE 8 CELL EXPANSION MARKET: CAGR PROJECTIONS
• 2.7 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
• 2.8 RESEARCH ASSUMPTIONS
• 2.9 MARKET FORECAST
  • TABLE 1 FACTOR ANALYSIS
• 2.10 RISK ANALYSIS
• 2.11 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 10 CELL EXPANSION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 11 CELL EXPANSION MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 12 CELL EXPANSION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 CELL EXPANSION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 GEOGRAPHICAL SNAPSHOT OF CELL EXPANSION MARKET

4 PREMIUM INSIGHTS

• 4.1 CELL EXPANSION MARKET OVERVIEW
  • FIGURE 15 GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET
• 4.2 ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT & COUNTRY (2023)
  • FIGURE 16 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC CELL EXPANSION MARKET IN 2023
• 4.3 CELL EXPANSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.4 CELL EXPANSION MARKET SHARE, BY END USER, 2023
  • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 19 CELL EXPANSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 2 CELL EXPANSION MARKET: IMPACT ANALYSIS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing incidence of chronic diseases
  • FIGURE 20 CANCER INCIDENCE, BY REGION, 2022
  • FIGURE 21 US: PERCENTAGE OF DEATHS CAUSED BY HEART DISEASE, 2021
    • 5.2.1.2 Rising government investments in cell-based research and therapies
    • 5.2.1.3 Growing focus on personalized medicine
  • FIGURE 22 PERCENTAGE OF PERSONALIZED MEDICINES IN FDA'S NEW DRUG APPROVALS, 2015-2022
    • 5.2.1.4 Increasing GMP certifications for cell therapy production facilities
    • 5.2.1.5 Growing strategic alliances for development of cell-based therapeutics
  • TABLE 3 STRATEGIC ALLIANCES IN CELL-BASED THERAPEUTICS
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Ethical concerns regarding research in cell biology
    • 5.2.2.2 High cost of cell-based therapies
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High growth opportunities in emerging markets
    • 5.2.3.2 Growing utility of 3D cell expansion technology
    • 5.2.3.3 Growing automation in cell therapy manufacturing
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Concerns regarding supply chain logistics
    • 5.2.4.2 Challenges related to scale-up of cell and gene therapies
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Single-use technology
  • TABLE 4 ADVANTAGES OF SINGLE-USE BIOREACTORS AND CONVENTIONAL BIOREACTORS
    • 5.3.1.2 Automated cell expansion
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 High-throughput screening
    • 5.3.2.2 Single-cell analysis
  • 5.3.3 ADJACENT TECHNOLOGIES
    • 5.3.3.1 Microfluidics and organ-on-a-chip
    • 5.3.3.2 3D bioprinting
• 5.4 TRADE DATA
  • TABLE 5 IMPORT VALUE FOR CELL CULTURE MEDIA, 2018-2022 (USD THOUSAND)
  • TABLE 6 EXPORT VALUE FOR CELL CULTURE MEDIA, 2018-2022 (USD THOUSAND)
  • TABLE 7 IMPORT VOLUME FOR CELL CULTURE MEDIA, 2018-2022 (TONS)
  • TABLE 8 EXPORT VOLUME FOR CELL CULTURE MEDIA, 2018-2022 (TONS)
• 5.5 SUPPLY CHAIN ANALYSIS
  • FIGURE 23 CELL EXPANSION MARKET: SUPPLY CHAIN ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
  • FIGURE 24 CELL EXPANSION MARKET: VALUE CHAIN ANALYSIS
• 5.7 PRICING ANALYSIS
  • TABLE 9 AVERAGE SELLING PRICE OF CELL EXPANSION PRODUCTS
  • TABLE 10 AVERAGE SELLING PRICE OF CELL EXPANSION PRODUCTS, BY REGION
• 5.8 ECOSYSTEM ANALYSIS
  • FIGURE 25 CELL EXPANSION MARKET: ECOSYSTEM ANALYSIS
  • 5.8.1 RAW MATERIAL VENDORS IN CELL EXPANSION MARKET
  • TABLE 11 CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS
  • 5.8.2 PRODUCT VENDORS IN CELL EXPANSION MARKET
  • TABLE 12 CELL EXPANSION MARKET: ROLE OF PRODUCT VENDORS
  • 5.8.3 END USERS IN CELL EXPANSION MARKET
  • TABLE 13 CELL EXPANSION MARKET: ROLE OF END USERS
  • 5.8.4 REGULATORY BODIES GOVERNING CELL EXPANSION MARKET
  • TABLE 14 CELL EXPANSION MARKET: ROLE OF REGULATORY BODIES
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.10 PATENT ANALYSIS
  • 5.10.1 METHODOLOGY
  • 5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
  • TABLE 15 PATENTS FILED, 2014-2024
  • 5.10.3 INNOVATION AND PATENT APPLICATIONS
  • FIGURE 27 TOTAL NUMBER OF PATENTS GRANTED, 2014-2024
  • 5.10.4 TOP APPLICANTS
  • FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2024
  • TABLE 16 TOP 20 PATENT OWNERS IN CELL EXPANSION MARKET, 2014-2024
  • TABLE 17 PATENTS IN CELL EXPANSION MARKET, 2024
• 5.11 KEY CONFERENCES AND EVENTS
  • TABLE 18 CELL EXPANSION MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
• 5.12 REGULATORY LANDSCAPE
  • 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12.2 REGULATORY SCENARIO
  • TABLE 23 CELL EXPANSION MARKET: REGULATORY GUIDELINES
• 5.13 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 24 CELL EXPANSION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.13.1 THREAT OF NEW ENTRANTS
  • 5.13.2 THREAT OF SUBSTITUTES
  • 5.13.3 BARGAINING POWER OF SUPPLIERS
  • 5.13.4 BARGAINING POWER OF BUYERS
  • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL EXPANSION PRODUCTS
  • 5.14.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS
  • 5.14.3 BUYING CRITERIA FOR CELL EXPANSION MARKET
  • FIGURE 30 KEY BUYING CRITERIA FOR END USERS
  • TABLE 25 BUYING CRITERIA FOR CELL EXPANSION PRODUCTS, BY END USER
• 5.15 INVESTMENT/FUNDING ACTIVITIES

6 CELL EXPANSION MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 26 CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• 6.2 CONSUMABLES
  • TABLE 27 CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 28 CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 29 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 MIDDLE EAST: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.1 MEDIA
  • TABLE 35 MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 36 MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 37 NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 EUROPE: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 MIDDLE EAST: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 GCC COUNTRIES: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.1 Serum-free media
      • 6.2.1.1.1 Increasing utilization of serum-free components in cell research to promote market growth
  • TABLE 43 SERUM-FREE MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 MIDDLE EAST: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 GCC COUNTRIES: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2 Classical media & salts
      • 6.2.1.2.1 Used in cell expansion to provide supportive environment for growth and proliferation of cultured cells
  • TABLE 50 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 MIDDLE EAST: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 GCC COUNTRIES: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.3 Stem cell culture media
      • 6.2.1.3.1 Rising investments and funding in stem cell research to support market growth
  • TABLE 57 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 MIDDLE EAST: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 GCC COUNTRIES: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.4 Chemically defined media
      • 6.2.1.4.1 Increasing number of cell-based research practices to drive market
  • TABLE 64 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 MIDDLE EAST: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 GCC COUNTRIES: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.5 Specialty media
      • 6.2.1.5.1 Growing focus on advancement of regenerative medicine to drive growth
  • TABLE 71 EXAMPLES OF SPECIALTY MEDIA OFFERED BY KEY PLAYERS
  • TABLE 72 SPECIALTY MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 76 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 MIDDLE EAST: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 GCC COUNTRIES: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.6 Other media types
  • TABLE 79 OTHER MEDIA TYPES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 EUROPE: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 LATIN AMERICA: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 MIDDLE EAST: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 GCC COUNTRIES: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.2 REAGENTS
    • 6.2.2.1 Rising need for unique signaling molecules for cell proliferation to boost growth
  • TABLE 86 REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 MIDDLE EAST: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.3 SERA
    • 6.2.3.1 Growing R&D activities to drive demand for sera
  • TABLE 93 SERA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 EUROPE: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 97 LATIN AMERICA: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 98 MIDDLE EAST: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 GCC COUNTRIES: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.4 VESSELS
  • TABLE 100 VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 VESSELS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 EUROPE: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 LATIN AMERICA: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 MIDDLE EAST: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 GCC COUNTRIES: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4.1 Roller/roux bottles
      • 6.2.4.1.1 Offer economic mean for large-scale cell expansion
  • TABLE 108 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 109 NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 ASIA PACIFIC ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 MIDDLE EAST: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 GCC COUNTRIES: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4.2 Cell factory systems/cell stacks
      • 6.2.4.2.1 Provide high-throughput and scalable solutions for large-scale cell expansion
  • TABLE 115 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 119 LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 120 MIDDLE EAST: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 121 GCC COUNTRIES: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4.3 Flasks
      • 6.2.4.3.1 Commonly used to offer large surface area for cell expansion
  • TABLE 122 FLASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 EUROPE: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 MIDDLE EAST: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 128 GCC COUNTRIES: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4.4 Multiwell plates
      • 6.2.4.4.1 Single platform for multiple processes to obtain high-volume culture
  • TABLE 129 MULTIWELL PLATES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 MIDDLE EAST: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4.5 Cell expansion bags
      • 6.2.4.5.1 Reduce risk of cross-contamination and ensure consistent culture conditions
  • TABLE 136 CELL EXPANSION BAGS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 EUROPE: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 MIDDLE EAST: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 142 GCC COUNTRIES: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4.6 Petri dishes
      • 6.2.4.6.1 Ease of use to support market growth
  • TABLE 143 PETRI DISHES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 144 NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 MIDDLE EAST: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 149 GCC COUNTRIES: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.5 OTHER CONSUMABLES
  • TABLE 150 OTHER CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 151 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 156 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.3 EQUIPMENT
  • TABLE 157 EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 162 LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 164 GCC COUNTRIES: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.1 BIOREACTORS
  • TABLE 165 BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 166 BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 168 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 169 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 171 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 MIDDLE EAST: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1.1 Bioreactors, by Usage
      • 6.3.1.1.1 Conventional Bioreactors
        • 6.3.1.1.1.1 Widely used for large-scale manufacturing
  • TABLE 174 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 175 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 176 EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 178 LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 MIDDLE EAST: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 180 GCC COUNTRIES: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1.1.2 Single-use bioreactors
      • 6.3.1.1.2.1 Increasing adoption of single-use equipment to boost segment growth
  • TABLE 181 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 182 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 183 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 185 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 186 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 187 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1.2 Bioreactors, by Type
      • 6.3.1.2.1 Microcarrier bioreactors
        • 6.3.1.2.1.1 Offers high density of cells within small volume of media
  • TABLE 188 MICROCARRIER BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 189 NORTH AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 EUROPE: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 192 LATIN AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 193 MIDDLE EAST: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 194 GCC COUNTRIES: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1.2.2 Suspension-based independent bioreactors
      • 6.3.1.2.2.1 Offer controlled environment for cell growth-key factor driving market growth
  • TABLE 195 SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 196 NORTH AMERICA: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 EUROPE: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 200 MIDDLE EAST: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 201 GCC COUNTRIES: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1.2.3 Hollow fiber bioreactors
      • 6.3.1.2.3.1 Growing demand for perfusion-based cell expansion to drive growth
  • TABLE 202 HOLLOW FIBER BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 203 NORTH AMERICA: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 204 EUROPE: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 206 LATIN AMERICA: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 207 MIDDLE EAST: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1.2.4 Other bioreactors
  • TABLE 209 OTHER BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 210 NORTH AMERICA: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 211 EUROPE: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 213 LATIN AMERICA: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 214 MIDDLE EAST: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 215 GCC COUNTRIES: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.2 AUTOMATED CELL EXPANSION SYSTEMS
    • 6.3.2.1 Increasing automation in cell & gene therapy manufacturing to boost demand
  • TABLE 216 AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 217 NORTH AMERICA: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 218 EUROPE: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 221 MIDDLE EAST: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3 OTHER CELL EXPANSION EQUIPMENT
  • TABLE 223 OTHER CELL EXPANSION EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 224 NORTH AMERICA: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 225 EUROPE: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 227 LATIN AMERICA: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 228 MIDDLE EAST: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 CELL EXPANSION MARKET, BY CELL TYPE

• 7.1 INTRODUCTION
  • TABLE 230 CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• 7.2 HUMAN CELLS
  • TABLE 231 CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 CELL EXPANSION MARKET FOR HUMAN CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 233 NORTH AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 234 EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 236 LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 237 MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.2.1 STEM CELLS
  • TABLE 239 CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 240 CELL EXPANSION MARKET FOR STEM CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 241 NORTH AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 242 EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 244 LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 245 MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 7.2.1.1 Adult stem cells
      • 7.2.1.1.1 Rising funding for advancement of stem cell-based therapies to drive market
  • TABLE 247 CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 248 NORTH AMERICA: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 249 EUROPE: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 251 LATIN AMERICA: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 252 MIDDLE EAST: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 7.2.1.2 Embryonic stem cells
      • 7.2.1.2.1 Rising prevalence of chronic diseases to support market growth
  • TABLE 254 CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 255 NORTH AMERICA: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 256 EUROPE: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 258 LATIN AMERICA: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 259 MIDDLE EAST: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 260 GCC COUNTRIES: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 7.2.1.3 Induced pluripotent stem cells
      • 7.2.1.3.1 Growing number of collaborations for advancement of iPSC-based therapies to drive market
  • TABLE 261 CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 262 NORTH AMERICA: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 263 EUROPE: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 264 ASIA PACIFIC: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 265 LATIN AMERICA: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 266 MIDDLE EAST: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 267 GCC COUNTRIES: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)

• 7.2.2 DIFFERENTIATED CELLS
  • 7.2.2.1 Increasing research activities to drive growth
• TABLE 268 CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 269 NORTH AMERICA: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 270 EUROPE: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 271 ASIA PACIFIC: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 272 LATIN AMERICA: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 273 MIDDLE EAST: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 274 GCC COUNTRIES: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.3 ANIMAL CELLS
  • TABLE 275 CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 CELL EXPANSION MARKET FOR ANIMAL CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 277 NORTH AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 278 EUROPE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 279 ASIA PACIFIC: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 280 LATIN AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 281 MIDDLE EAST: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 282 GCC COUNTRIES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3.1 CHINESE HAMSTER OVARY CELLS
    • 7.3.1.1 Growing strategic alliances for development of novel biopharmaceuticals to drive growth
  • TABLE 283 CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 284 NORTH AMERICA: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 285 EUROPE: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 286 ASIA PACIFIC: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 287 LATIN AMERICA: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 288 MIDDLE EAST: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 289 GCC COUNTRIES: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3.2 MOUSE EMBRYONIC STEM CELLS
    • 7.3.2.1 Growing research activities to develop innovative therapies to support market growth
  • TABLE 290 CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 291 NORTH AMERICA: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 292 EUROPE: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 294 LATIN AMERICA: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 295 MIDDLE EAST: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 296 GCC COUNTRIES: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3.3 OTHER ANIMAL CELLS
  • TABLE 297 CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 298 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 299 EUROPE: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 300 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 301 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 302 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 303 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.4 OTHER CELL TYPES
  • TABLE 304 CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 305 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 306 EUROPE: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 308 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 309 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 310 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022-2029 (USD MILLION)

8 CELL EXPANSION MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • TABLE 311 CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 8.2 BIOPHARMACEUTICAL PRODUCTION
  • TABLE 312 CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 313 CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 314 NORTH AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 315 EUROPE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 316 ASIA PACIFIC: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 317 LATIN AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 318 MIDDLE EAST: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 319 GCC COUNTRIES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.1 MONOCLONAL ANTIBODY PRODUCTION
    • 8.2.1.1 Increasing regulatory approvals for mAb treatments to drive growth
  • TABLE 320 CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 321 NORTH AMERICA: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 322 EUROPE: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 324 LATIN AMERICA: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 325 MIDDLE EAST: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 326 GCC COUNTRIES: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.2 VACCINE PRODUCTION
    • 8.2.2.1 Rising incidence of infectious diseases to drive growth
  • TABLE 327 CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 328 NORTH AMERICA: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 329 EUROPE: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 330 ASIA PACIFIC: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 331 LATIN AMERICA: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 332 MIDDLE EAST: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 333 GCC COUNTRIES: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
  • TABLE 334 CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 335 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 336 EUROPE: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 337 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 338 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 339 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 340 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.3 TISSUE ENGINEERING & REGENERATIVE MEDICINE
  • TABLE 341 CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 342 CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 343 NORTH AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 344 EUROPE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 345 ASIA PACIFIC: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 346 LATIN AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 347 MIDDLE EAST: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 348 GCC COUNTRIES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3.1 CELL & GENE THERAPY
    • 8.3.1.1 Increasing investments in cell-based therapies to drive market
  • TABLE 349 CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 350 NORTH AMERICA: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 351 EUROPE: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 352 ASIA PACIFIC: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 353 LATIN AMERICA: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 354 MIDDLE EAST: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 355 GCC COUNTRIES: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
  • TABLE 356 CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 357 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 358 EUROPE: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 359 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 360 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 361 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 362 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.4 DRUG SCREENING & DEVELOPMENT
  • 8.4.1 INCREASING DEMAND FOR NOVEL THERAPEUTICS TO SUPPORT MARKET GROWTH
  • TABLE 363 CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 364 NORTH AMERICA: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 365 EUROPE: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 366 ASIA PACIFIC: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 367 LATIN AMERICA: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 368 MIDDLE EAST: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 369 GCC COUNTRIES: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.5 OTHER APPLICATIONS
  • TABLE 370 CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 371 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 372 EUROPE: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 373 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 374 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 375 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 376 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)

9 CELL EXPANSION MARKET, BY END USER

• 9.1 INTRODUCTION
  • TABLE 377 CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.2.1 GROWING STRATEGIC ALLIANCES BY KEY MARKET PLAYERS TO DRIVE GROWTH
  • TABLE 378 CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 379 NORTH AMERICA: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 380 EUROPE: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 381 ASIA PACIFIC: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 382 LATIN AMERICA: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 383 MIDDLE EAST: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 384 GCC COUNTRIES: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• 9.3 RESEARCH & ACADEMIC INSTITUTES
  • 9.3.1 INCREASING GOVERNMENT FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET
  • TABLE 385 CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 386 NORTH AMERICA: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 387 EUROPE: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 388 ASIA PACIFIC: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 389 LATIN AMERICA: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 390 MIDDLE EAST: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 391 GCC COUNTRIES: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• 9.4 HOSPITALS & DIAGNOSTIC LABORATORIES
  • 9.4.1 GROWING DEMAND FOR CELL-BASED THERAPIES TO PROPEL MARKET
  • TABLE 392 CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 393 NORTH AMERICA: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 394 EUROPE: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 395 ASIA PACIFIC: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 396 LATIN AMERICA: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 397 MIDDLE EAST: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 398 GCC COUNTRIES: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
• 9.5 OTHER END USERS
  • TABLE 399 CELL EXPANSION MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 400 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 401 EUROPE: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 402 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 403 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 404 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 405 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)

10 CELL EXPANSION MARKET, BY REGION

• 10.1 INTRODUCTION
  • TABLE 406 CELL EXPANSION MARKET, BY REGION, 2022-2029 (USD MILLION)
• 10.2 NORTH AMERICA
  • FIGURE 31 NORTH AMERICA: CELL EXPANSION MARKET SNAPSHOT
  • TABLE 407 NORTH AMERICA: CELL EXPANSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 408 NORTH AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 409 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 410 NORTH AMERICA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 411 NORTH AMERICA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 412 NORTH AMERICA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 413 NORTH AMERICA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 414 NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 415 NORTH AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 416 NORTH AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 417 NORTH AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 418 NORTH AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 419 NORTH AMERICA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 420 NORTH AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 421 NORTH AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 422 NORTH AMERICA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.2.1 US
    • 10.2.1.1 Rising investments in cell-based research to drive market
  • TABLE 423 US: CELL & GENE THERAPY APPROVALS, 2022
  • TABLE 424 US: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 425 US: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 426 US: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 427 US: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 428 US: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 429 US: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 430 US: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 431 US: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 432 US: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 433 US: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 434 US: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 435 US: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 436 US: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 437 US: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 438 US: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.2.2 CANADA
    • 10.2.2.1 Growing funding for advancement of regenerative medicine to support market growth
  • TABLE 439 CANADA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 440 CANADA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 441 CANADA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 442 CANADA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 443 CANADA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 444 CANADA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 445 CANADA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 446 CANADA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 447 CANADA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 448 CANADA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 449 CANADA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 450 CANADA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 451 CANADA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 452 CANADA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 453 CANADA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.2.3 NORTH AMERICA: RECESSION IMPACT
• 10.3 EUROPE
  • TABLE 454 EUROPE: NEW CELL THERAPY APPROVALS, 2022
  • TABLE 455 EUROPE: CELL EXPANSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 456 EUROPE: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 457 EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 458 EUROPE: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 459 EUROPE: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 460 EUROPE: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 461 EUROPE: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 462 EUROPE: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 463 EUROPE: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 464 EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 465 EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 466 EUROPE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 467 EUROPE: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 468 EUROPE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 469 EUROPE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 470 EUROPE: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.1 GERMANY
    • 10.3.1.1 Increasing number of strategic alliances for development of cell-based therapies to drive market
  • TABLE 471 GERMANY: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 472 GERMANY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 473 GERMANY: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 474 GERMANY: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 475 GERMANY: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 476 GERMANY: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 477 GERMANY: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 478 GERMANY: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 479 GERMANY: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 480 GERMANY: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 481 GERMANY: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 482 GERMANY: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 483 GERMANY: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 484 GERMANY: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 485 GERMANY: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.2 UK
    • 10.3.2.1 Increasing focus on advancement of regenerative medicine to propel market
  • TABLE 486 UK: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 487 UK: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 488 UK: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 489 UK: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 490 UK: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 491 UK: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 492 UK: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 493 UK: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 494 UK: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 495 UK: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 496 UK: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 497 UK: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 498 UK: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 499 UK: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 500 UK: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.3 FRANCE
    • 10.3.3.1 Growing strategic alliances for development of advanced cell and gene therapies to support market growth
  • TABLE 501 FRANCE: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 502 FRANCE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 503 FRANCE: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 504 FRANCE: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 505 FRANCE: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 506 FRANCE: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 507 FRANCE: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 508 FRANCE: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 509 FRANCE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 510 FRANCE: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 511 FRANCE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 512 FRANCE: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 513 FRANCE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 514 FRANCE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 515 FRANCE: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.4 ITALY
    • 10.3.4.1 Increased focus on life sciences R&D activities and growing biotech industry to drive market
  • TABLE 516 ITALY: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 517 ITALY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 518 ITALY: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 519 ITALY: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 520 ITALY: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 521 ITALY: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 522 ITALY: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 523 ITALY: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 524 ITALY: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 525 ITALY: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 526 ITALY: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 527 ITALY: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 528 ITALY: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 529 ITALY: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 530 ITALY: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.5 SPAIN
    • 10.3.5.1 Expansion of biotech companies to support market growth
  • TABLE 531 SPAIN: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 532 SPAIN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 533 SPAIN: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 534 SPAIN: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 535 SPAIN: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 536 SPAIN: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 537 SPAIN: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 538 SPAIN: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 539 SPAIN: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 540 SPAIN: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 541 SPAIN: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 542 SPAIN: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 543 SPAIN: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 544 SPAIN: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 545 SPAIN: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.6 REST OF EUROPE
  • TABLE 546 REST OF EUROPE: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 547 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 548 REST OF EUROPE: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 549 REST OF EUROPE: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 550 REST OF EUROPE: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 551 REST OF EUROPE: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 552 REST OF EUROPE: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 553 REST OF EUROPE: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 554 REST OF EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 555 REST OF EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 556 REST OF EUROPE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 557 REST OF EUROPE: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 558 REST OF EUROPE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 559 REST OF EUROPE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 560 REST OF EUROPE: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.7 EUROPE: RECESSION IMPACT

• 10.4 ASIA PACIFIC
  • FIGURE 32 ASIA PACIFIC: CELL EXPANSION MARKET SNAPSHOT
  • TABLE 561 ASIA PACIFIC: CELL EXPANSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 562 ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 563 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 564 ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 565 ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 566 ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 567 ASIA PACIFIC: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 568 ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 569 ASIA PACIFIC: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 570 ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 571 ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 572 ASIA PACIFIC: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 573 ASIA PACIFIC: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 574 ASIA PACIFIC: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 575 ASIA PACIFIC: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 576 ASIA PACIFIC: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.1 CHINA
    • 10.4.1.1 Increasing R&D expenditure and rising number of clinical trials for novel therapeutics to propel market
  • TABLE 577 CHINA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 578 CHINA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 579 CHINA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 580 CHINA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 581 CHINA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 582 CHINA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 583 CHINA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 584 CHINA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 585 CHINA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 586 CHINA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 587 CHINA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 588 CHINA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 589 CHINA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 590 CHINA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 591 CHINA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.2 JAPAN
    • 10.4.2.1 Rising investments for advancement of biotechnology sector to boost market growth
  • TABLE 592 JAPAN: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 593 JAPAN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 594 JAPAN: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 595 JAPAN: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 596 JAPAN: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 597 JAPAN: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 598 JAPAN: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 599 JAPAN: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 600 JAPAN: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 601 JAPAN: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 602 JAPAN: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 603 JAPAN: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 604 JAPAN: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 605 JAPAN: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 606 JAPAN: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.3 INDIA
    • 10.4.3.1 Rising funding to boost biopharmaceutical sector and growing focus on development of cell-based therapies to propel market
  • TABLE 607 INDIA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 608 INDIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 609 INDIA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 610 INDIA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 611 INDIA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 612 INDIA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 613 INDIA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 614 INDIA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 615 INDIA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 616 INDIA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 617 INDIA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 618 INDIA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 619 INDIA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 620 INDIA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 621 INDIA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.4 SOUTH KOREA
    • 10.4.4.1 Growing strategic alliances and investments in research to drive market
  • TABLE 622 SOUTH KOREA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 623 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 624 SOUTH KOREA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 625 SOUTH KOREA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 626 SOUTH KOREA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 627 SOUTH KOREA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 628 SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 629 SOUTH KOREA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 630 SOUTH KOREA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 631 SOUTH KOREA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 632 SOUTH KOREA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 633 SOUTH KOREA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 634 SOUTH KOREA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 635 SOUTH KOREA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 636 SOUTH KOREA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Growing life science sector to drive market
  • TABLE 637 AUSTRALIA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 638 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 639 AUSTRALIA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 640 AUSTRALIA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 641 AUSTRALIA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 642 AUSTRALIA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 643 AUSTRALIA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 644 AUSTRALIA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 645 AUSTRALIA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 646 AUSTRALIA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 647 AUSTRALIA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 648 AUSTRALIA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 649 AUSTRALIA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 650 AUSTRALIA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 651 AUSTRALIA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.6 REST OF ASIA PACIFIC
  • TABLE 652 REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 653 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 654 REST OF ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 655 REST OF ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 656 REST OF ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 657 REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 658 REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 659 REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 660 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 661 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 662 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 663 REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 664 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 665 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 666 REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.7 ASIA PACIFIC: RECESSION IMPACT
• 10.5 LATIN AMERICA
  • TABLE 667 LATIN AMERICA: CELL EXPANSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 668 LATIN AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 669 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 670 LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 671 LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 672 LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 673 LATIN AMERICA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 674 LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 675 LATIN AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 676 LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 677 LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 678 LATIN AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 679 LATIN AMERICA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 680 LATIN AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 681 LATIN AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 682 LATIN AMERICA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5.1 BRAZIL
    • 10.5.1.1 Increasing demand for biopharmaceuticals to drive market
  • TABLE 683 BRAZIL: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 684 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 685 BRAZIL: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 686 BRAZIL: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 687 BRAZIL: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 688 BRAZIL: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 689 BRAZIL: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 690 BRAZIL: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 691 BRAZIL: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 692 BRAZIL: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 693 BRAZIL: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 694 BRAZIL: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 695 BRAZIL: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 696 BRAZIL: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 697 BRAZIL: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5.2 MEXICO
    • 10.5.2.1 Increasing government support for biopharmaceutical production to support market growth
  • TABLE 698 MEXICO: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 699 MEXICO: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 700 MEXICO: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 701 MEXICO: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 702 MEXICO: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 703 MEXICO: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 704 MEXICO: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 705 MEXICO: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 706 MEXICO: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 707 MEXICO: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 708 MEXICO: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 709 MEXICO: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 710 MEXICO: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 711 MEXICO: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 712 MEXICO: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5.3 REST OF LATIN AMERICA
  • TABLE 713 REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 714 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 715 REST OF LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 716 REST OF LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 717 REST OF LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 718 REST OF LATIN AMERICA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 719 REST OF LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 720 REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 721 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 722 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 723 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 724 REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 725 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 726 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 727 REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5.4 LATIN AMERICA: RECESSION IMPACT
• 10.6 MIDDLE EAST
  • TABLE 728 MIDDLE EAST: CELL EXPANSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 729 MIDDLE EAST: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 730 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 731 MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 732 MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 733 MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 734 MIDDLE EAST: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 735 MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 736 MIDDLE EAST: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 737 MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 738 MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 739 MIDDLE EAST: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 740 MIDDLE EAST: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 741 MIDDLE EAST: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 742 MIDDLE EAST: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 743 MIDDLE EAST: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.6.1 GCC COUNTRIES
  • TABLE 744 GCC COUNTRIES: CELL EXPANSION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 745 GCC COUNTRIES: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 746 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 747 GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 748 GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 749 GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 750 GCC COUNTRIES: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 751 GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 752 GCC COUNTRIES: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 753 GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 754 GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 755 GCC COUNTRIES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 756 GCC COUNTRIES: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 757 GCC COUNTRIES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 758 GCC COUNTRIES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 759 GCC COUNTRIES: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.1.1 Saudi Arabia
      • 10.6.1.1.1 Increasing focus of key players on expansion strategies to drive market
  • TABLE 760 SAUDI ARABIA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 761 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 762 SAUDI ARABIA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 763 SAUDI ARABIA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 764 SAUDI ARABIA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 765 SAUDI ARABIA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 766 SAUDI ARABIA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 767 SAUDI ARABIA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 768 SAUDI ARABIA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 769 SAUDI ARABIA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 770 SAUDI ARABIA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 771 SAUDI ARABIA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 772 SAUDI ARABIA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 773 SAUDI ARABIA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 774 SAUDI ARABIA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.1.2 United Arab Emirates
      • 10.6.1.2.1 Governmental initiatives to support market growth
  • TABLE 775 UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 776 UNITED ARAB EMIRATES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 777 UNITED ARAB EMIRATES: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 778 UNITED ARAB EMIRATES: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 779 UNITED ARAB EMIRATES: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 780 UNITED ARAB EMIRATES: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 781 UNITED ARAB EMIRATES: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 782 UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 783 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 784 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 785 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 786 UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 787 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 788 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 789 UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.1.3 Rest of GCC countries
  • TABLE 790 REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 791 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 792 REST OF GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 793 REST OF GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 794 REST OF GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 795 REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 796 REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 797 REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 798 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 799 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 800 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 801 REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 802 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 803 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 804 REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.6.2 REST OF THE MIDDLE EAST
  • TABLE 805 REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 806 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 807 REST OF MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 808 REST OF MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 809 REST OF MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 810 REST OF MIDDLE EAST: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 811 REST OF MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 812 REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 813 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 814 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 815 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 816 REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 817 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 818 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 819 REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.6.3 MIDDLE EAST: RECESSION IMPACT
• 10.7 AFRICA
  • 10.7.1 RISING FUNDING ACTIVITIES FOR BIOPHARMA AND CELL & GENE THERAPY TO FUEL MARKET GROWTH
  • 10.7.2 AFRICA: RECESSION IMPACT
  • TABLE 820 AFRICA: CELL EXPANSION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 821 AFRICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 822 AFRICA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 823 AFRICA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 824 AFRICA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 825 AFRICA: BIOREACTORS MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 826 AFRICA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 827 AFRICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
  • TABLE 828 AFRICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 829 AFRICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 830 AFRICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 831 AFRICA: CELL EXPANSION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 832 AFRICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 833 AFRICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 834 AFRICA: CELL EXPANSION MARKET, BY END USER, 2022-2029 (USD MILLION)

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
  • TABLE 835 STRATEGIES ADOPTED BY KEY PLAYERS IN CELL EXPANSION MARKET, 2021-2024
• 11.3 REVENUE SHARE ANALYSIS
  • FIGURE 33 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN CELL EXPANSION MARKET, 2019-2023 (USD MILLION)
• 11.4 MARKET SHARE ANALYSIS
  • FIGURE 34 CELL EXPANSION MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • TABLE 836 CELL EXPANSION MARKET: DEGREE OF COMPETITION
• 11.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 35 BRAND/PRODUCT COMPARATIVE ANALYSIS
• 11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 11.6.1 STARS
  • 11.6.2 EMERGING LEADERS
  • 11.6.3 PERVASIVE PLAYERS
  • 11.6.4 PARTICIPANTS
  • FIGURE 36 CELL EXPANSION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• 11.7 COMPANY FOOTPRINT: KEY PLAYERS
  • 11.7.1 COMPANY FOOTPRINT
  • FIGURE 37 CELL EXPANSION MARKET: COMPANY FOOTPRINT
  • 11.7.2 REGIONAL FOOTPRINT
  • TABLE 837 CELL EXPANSION MARKET: REGIONAL FOOTPRINT
  • 11.7.3 PRODUCT FOOTPRINT
  • TABLE 838 CELL EXPANSION MARKET: PRODUCT FOOTPRINT
  • 11.7.4 APPLICATION FOOTPRINT
  • TABLE 839 CELL EXPANSION MARKET: APPLICATION FOOTPRINT
  • 11.7.5 END-USER FOOTPRINT
  • TABLE 840 CELL EXPANSION MARKET: END-USER FOOTPRINT
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 STARTING BLOCKS
  • 11.8.3 RESPONSIVE COMPANIES
  • 11.8.4 DYNAMIC COMPANIES
  • FIGURE 38 CELL EXPANSION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES
  • TABLE 841 CELL EXPANSION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 842 CELL EXPANSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SMES, 2023
• 11.9 VALUATION AND FINANCIAL METRICS OF CELL EXPANSION VENDORS
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• 11.10 COMPETITIVE SCENARIO
  • 11.10.1 PRODUCT LAUNCHES
  • TABLE 843 CELL EXPANSION MARKET: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2024
  • 11.10.2 DEALS
  • TABLE 844 CELL EXPANSION MARKET: DEALS, JANUARY 2021-JANUARY 2024
  • 11.10.3 EXPANSIONS
  • TABLE 845 CELL EXPANSION MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2024

12 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) **

• 12.1 INTRODUCTION
• 12.2 KEY PLAYERS
  • 12.2.1 THERMO FISHER SCIENTIFIC INC.
  • TABLE 846 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • TABLE 847 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 848 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
  • TABLE 849 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 850 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
  • 12.2.2 DANAHER CORPORATION
  • TABLE 851 DANAHER CORPORATION: COMPANY OVERVIEW
  • FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • TABLE 852 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 853 DANAHER CORPORATION: PRODUCT LAUNCHES
  • TABLE 854 DANAHER CORPORATION: DEALS
  • TABLE 855 DANAHER CORPORATION: EXPANSIONS
  • TABLE 856 DANAHER CORPORATION: OTHER DEVELOPMENTS
  • 12.2.3 MERCK KGAA
  • TABLE 857 MERCK KGAA: COMPANY OVERVIEW
  • FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • TABLE 858 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 859 MERCK KGAA: DEALS
  • TABLE 860 MERCK KGAA: EXPANSIONS
  • 12.2.4 SARTORIUS AG
  • TABLE 861 SARTORIUS AG: COMPANY OVERVIEW
  • FIGURE 44 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • TABLE 862 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 863 SARTORIUS AG: DEALS
  • TABLE 864 SARTORIUS AG: EXPANSIONS
  • 12.2.5 CORNING INCORPORATED
  • TABLE 865 CORNING INCORPORATED: COMPANY OVERVIEW
  • FIGURE 45 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
  • TABLE 866 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 867 CORNING INCORPORATED: PRODUCT LAUNCHES
  • TABLE 868 CORNING INCORPORATED: DEALS
  • 12.2.6 LONZA
  • TABLE 869 LONZA: COMPANY OVERVIEW
  • FIGURE 46 LONZA: COMPANY SNAPSHOT (2023)
  • TABLE 870 LONZA: PRODUCTS OFFERED
  • TABLE 871 LONZA: PRODUCT LAUNCHES
  • TABLE 872 LONZA: DEALS
  • TABLE 873 LONZA: EXPANSIONS
  • 12.2.7 TERUMO CORPORATION
  • TABLE 874 TERUMO CORPORATION: COMPANY OVERVIEW
  • FIGURE 47 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 875 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 876 TERUMO CORPORATION: PRODUCT LAUNCHES
  • TABLE 877 TERUMO CORPORATION: DEALS
  • 12.2.8 EPPENDORF SE
  • TABLE 878 EPPENDORF SE: COMPANY OVERVIEW
  • FIGURE 48 EPPENDORF SE: COMPANY SNAPSHOT (2022)
  • TABLE 879 EPPENDORF SE: PRODUCTS OFFERED
  • TABLE 880 EPPENDORF SE: PRODUCT LAUNCHES
  • TABLE 881 EPPENDORF SE: EXPANSIONS
  • 12.2.9 FUJIFILM CORPORATION
  • TABLE 882 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • FIGURE 49 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
  • TABLE 883 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 884 FUJIFILM CORPORATION: PRODUCT LAUNCHES
  • TABLE 885 FUJIFILM CORPORATION: DEALS
  • TABLE 886 FUJIFILM CORPORATION: EXPANSIONS
  • 12.2.10 BIO-TECHNE
  • TABLE 887 BIO-TECHNE: COMPANY OVERVIEW
  • FIGURE 50 BIO-TECHNE: COMPANY SNAPSHOT (2023)
  • TABLE 888 BIO-TECHNE: PRODUCTS OFFERED
  • TABLE 889 BIO-TECHNE: PRODUCT LAUNCHES
  • TABLE 890 BIO-TECHNE: DEALS
  • 12.2.11 REPLIGEN CORPORATION
  • TABLE 891 REPLIGEN CORPORATION: COMPANY OVERVIEW
  • FIGURE 51 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2023)
  • TABLE 892 REPLIGEN CORPORATION: PRODUCTS OFFERED
  • TABLE 893 REPLIGEN CORPORATION: DEALS
  • 12.2.12 GETINGE AB
  • TABLE 894 GETINGE AB: COMPANY OVERVIEW
  • FIGURE 52 GETINGE AB: COMPANY SNAPSHOT (2022)
  • TABLE 895 GETINGE AB: PRODUCTS OFFERED
  • TABLE 896 GETINGE AB: PRODUCT LAUNCHES
  • TABLE 897 GETINGE AB: DEALS
  • 12.2.13 BD
  • TABLE 898 BD: BUSINESS OVERVIEW
  • FIGURE 53 BD: COMPANY SNAPSHOT (2023)
  • TABLE 899 BD: PRODUCTS OFFERED
  • 12.2.14 MILTENYI BIOTEC
  • TABLE 900 MILTENYI BIOTEC: COMPANY OVERVIEW
  • TABLE 901 MILTENYI BIOTEC: PRODUCTS OFFERED
  • TABLE 902 MILTENYI BIOTEC: EXPANSIONS
  • 12.2.15 PERKINELMER INC.
  • TABLE 903 PERKINELMER INC.: COMPANY OVERVIEW
  • FIGURE 54 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
  • TABLE 904 PERKINELMER INC.: PRODUCTS OFFERED
  • TABLE 905 PERKINELMER INC.: DEALS
  • 12.2.16 STEMCELL TECHNOLOGIES
  • TABLE 906 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 907 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 908 STEMCELL TECHNOLOGIES: DEALS
  • 12.2.17 PROMOCELL GMBH
  • TABLE 909 PROMOCELL GMBH: COMPANY OVERVIEW
  • TABLE 910 PROMOCELL GMBH: PRODUCTS OFFERED
  • TABLE 911 PROMOCELL GMBH: PRODUCT LAUNCHES
  • 12.2.18 HIMEDIA LABORATORIES
  • TABLE 912 HIMEDIA LABORATORIES: COMPANY OVERVIEW
  • TABLE 913 HIMEDIA LABORATORIES: PRODUCTS OFFERED
• 12.3 OTHER PLAYERS
  • 12.3.1 TAKARA BIO INC.
  • TABLE 914 TAKARA BIO INC.: BUSINESS OVERVIEW
  • 12.3.2 SHANGHAI DUONING BIOTECHNOLOGY CO., LTD.
  • TABLE 915 SHANGHAI DUONING BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
  • 12.3.3 REPROCELL INC.
  • TABLE 916 REPROCELL INC.: BUSINESS OVERVIEW
  • TABLE 917 PBS BIOTECH, INC.: BUSINESS OVERVIEW
  • 12.3.4 ACROBIOSYSTEMS
  • TABLE 918 ACROBIOSYSTEMS: COMPANY OVERVIEW
  • 12.3.5 SOLIDA BIOTECH GMBH
  • TABLE 919 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
  • 12.3.6 BEIJING CYTONICHE BIOTECHNOLOGY CO., LTD.
  • TABLE 920 BEIJING CYTONICHE BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
  • 12.3.7 NEUROMICS
  • TABLE 921 NEUROMICS: BUSINESS OVERVIEW
  • 12.3.8 BIONET
  • TABLE 922 BIONET: BUSINESS OVERVIEW
  • 12.3.9 CELLEXUS
  • TABLE 923 CELLEXUS: BUSINESS OVERVIEW
• *Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

관련자료